| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S1608-FL, TGR-1202/Lenalidomide/CHOP or Benda +Ob | 1 | T | 1 TGR-1202 + Obinutuzumab | 103 | 26 | 4 | 0 | 0 | 0 | 0 | 01/23/2018 | 221 | 78 |
| 2 Lenalidomide + Obinutuzumab | 24 | 4 | 0 | 0 | 0 | 0 | ||||||||
| 3 CHOP + Obinutuzumab | 11 | 2 | 0 | 0 | 0 | 0 | ||||||||
| 4 Bendamustine + Obinutuzumab | 11 | 0 | 0 | 0 | 0 | 0 | ||||||||
| 72 | 10 | 0 | 0 | 0 | 0 | |||||||||
| S1826-HD, Adv, Age 12+, N+AVD vs BV+AVD | 1 | Y | 1 Nivolumab + AVD | 987 | 445 | 197 | 110 | 49 | 16 | 2 | 08/29/2019 | 344 | 159 | |
| 2 Brentuximab Vedotin + AVD | 449 | 202 | 113 | 49 | 17 | 2 | ||||||||
| 894 | 399 | 223 | 98 | 33 | 4 | |||||||||
| S1918-DLBCL, Adv, Age 75+, CC-486 +/- R-miniCHOP | 1 | Y | 1 CC-486 + R-miniCHOP | 422 | 18 | 17 | 8 | 5 | 1 | 0 | 05/25/2021 | 173 | 61 | |
| 2 R-miniCHOP | 17 | 16 | 8 | 4 | 2 | 0 | ||||||||
| 35 | 33 | 16 | 9 | 3 | 0 | |||||||||
| Yes | A051301-ABC DLBCL, Auto HCT and Ibrutinib/Placebo | 0 | E | Total Registrations | 66 | 1 | 1 | 0 | 0 | 0 | 10/12/2016 | 160 | 57 | |
| 66 | 1 | 1 | 0 | 0 | 0 | |||||||||
| 1 | E | Total Registrations | 12 | 0 | 0 | 0 | 0 | 0 | 10/12/2016 | |||||
| 12 | 0 | 0 | 0 | 0 | 0 | |||||||||
| E4412-HD, RR, Ipilimumab +Nivo +Brentuximab Vedotin | 1 | E | Total Registrations | 20 | 0 | 0 | 0 | 0 | 0 | 04/17/2019 | 104 | 64 | ||
| 20 | 0 | 0 | 0 | 0 | 0 | |||||||||
| EA4151-Lymph, AHCT +/-Ritux, MRD Neg | 0 | E | Total Registrations | 132 | 39 | 16 | 5 | 1 | 0 | 04/03/2018 | 185 | 81 | ||
| 132 | 39 | 16 | 5 | 1 | 0 | |||||||||
| 1 | E | Total Registrations | 103 | 35 | 17 | 8 | 3 | 0 | 04/03/2018 | |||||
| 103 | 35 | 17 | 8 | 3 | 0 | |||||||||
| EA4181-MCL, Randomization BR/CR v BR/CR-A v BR-A | 1 | E | Total Registrations | 64 | 31 | 13 | 7 | 3 | 0 | 12/13/2019 | 201 | 80 | ||
| 64 | 31 | 13 | 7 | 3 | 0 | |||||||||
| No | A051701-LYMPH, MYC/BC2 DHL&DEL, R-chemo+/-Venetoclax | 1 | T | Total Registrations | 34 | 1 | 0 | 0 | 0 | 0 | 01/02/2020 | 248 | 102 | |
| 34 | 1 | 0 | 0 | 0 | 0 | |||||||||
| ANHL1931-PMBCL, Chemo-Immunotherapy +/- Nivo | 1 | E | Total Registrations | 1 | 1 | 1 | 0 | 0 | 0 | 02/28/2022 | 62 | 13 | ||
| 1 | 1 | 1 | 0 | 0 | 0 | |||||||||
| E4402-NHL, Low Tumor, Compare Rituximab Dosing | 1 | E | Total Registrations | 5 | 0 | 0 | 0 | 0 | 0 | 11/09/2004 | ||||
| 5 | 0 | 0 | 0 | 0 | 0 | |||||||||